WSFS
DGX icon

Wilmington Savings Fund Society’s Quest Diagnostics DGX Stock Holding History

Wilmington Savings Fund Society’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Buy
554
+4
+0.7% +$785 ﹤0.01% 710
2026
Q1 		$108K Hold
550
– – ﹤0.01% 722
2025
Q4 		$95.4K Sell
550
-107
-16% -$19.5K ﹤0.01% 744
2025
Q3 		$125K Sell
657
-876
-57% -$155K ﹤0.01% 688
2025
Q2 		$275K Buy
1,533
+280
+22% +$48.6K ﹤0.01% 728
2025
Q1 		$212K Sell
1,253
-40
-3% -$6.57K ﹤0.01% 785
2024
Q4 		$195K Hold
1,293
– – ﹤0.01% 839
2024
Q3 		$201K Buy
+1,293
New +$193K ﹤0.01% 817

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Wilmington Savings Fund Society's DGX Position: Q2 2026 in Review

Wilmington Savings Fund Society increased its Quest Diagnostics (DGX) stake by 0.73% in Q2 2026, buying an estimated $785 and bringing the position to 554 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #710.

Wilmington Savings Fund Society first reported a position in DGX in Q3 2024 and has held it in 8 quarters since. The position peaked at $275K in Q2 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Wilmington Savings Fund Society held 554 shares of Quest Diagnostics worth $117K as of Q2 2026.
  • Wilmington Savings Fund Society bought 4 Quest Diagnostics shares in Q2 2026, an estimated $785.
  • Quest Diagnostics made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #710 holding.
  • Wilmington Savings Fund Society first reported a position in Quest Diagnostics in Q3 2024 and has held it in 8 quarters since.
  • Wilmington Savings Fund Society's Quest Diagnostics position peaked at $275K in Q2 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.